Showing results (41-50 of 317) with videos related to
Sort By:
Pageof 32
Nihon Jinzo Gakkai Shi|June 1, 1989
Influence of phenacetin and its metabolites on renal functionS Mineshita, A Toyoshima, T YazakiThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 21, 1998
Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammationL Jasmin, G Janni, H J Manz, et al.Brain Tumor Pathology|August 24, 2001
Fas ligand expression and depletion of T-cell infiltration in astrocytic tumorsM Ichinose, J Masuoka, T Shiraishi, et al.Neurosurgery|November 1, 1994
Antisense expression of protein kinase C alpha inhibits the growth and tumorigenicity of human glioblastoma cellsS Ahmad, T Mineta, R L Martuza, et al.Journal of Neurosurgery|June 1, 1991
Nucleolar organizer regions in various human brain tumorsT Shiraishi, K Tabuchi, T Mineta, et al.Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|July 29, 2010
Development of active catheter, active guide wire and micro sensor systemsY Haga, T Mineta, K Totsu, et al.Japanese Journal of Cancer Research : Gann|July 28, 2001
Expression of ICAD-l and ICAD-S in human brain tumor and its cleavage upon activation of apoptosis by anti-Fas antibodyJ Masuoka, T Shiraishi, M Ichinose, et al.Journal of Virology|March 23, 2000
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in miceP Sundaresan, W D Hunter, R L Martuza, et al.Cancer Research|February 24, 2001
In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunityT Todo, R L Martuza, M J Dallman, et al.Proceedings of the National Academy of Sciences of the United States of America|May 17, 2001
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killingT Todo, R L Martuza, S D Rabkin, et al.Pageof 32